NAT10 and head and neck squamous cell carcinoma: A previous report showed that NAT10 could act as a potential biomarker for HNSCC [18], however, this study did not explore whether the mRNA ac4C modification could promote HNSCC progression and whether NAT10 has a role in LN metastasis of HNSCC or not.